Pharmacometabolomics for the study of lipid-lowering therapies: opportunities and challenges

E Gianazza, M Brioschi, A Iezzi, G Paglia… - International Journal of …, 2023 - mdpi.com
Lipid-lowering therapies are widely used to prevent the development of atherosclerotic
cardiovascular disease (ASCVD) and related mortality worldwide.“Omics” technologies have …

Sera metabolomics characterization of patients at different stages in wuhan identifies critical biomarkers of COVID-19

M Gu, H Pan, Y Yuan, X Zhou, L Chen… - Frontiers in Cellular …, 2022 - frontiersin.org
We have witnessed the 2-year-long global rampage of COVID-19 caused by the wide
spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However …

Metabolic biomarkers in cancer

K Szczepski, I Al-Younis, M Dhahri, JI Lachowicz… - Metabolomics, 2023 - Elsevier
Over the course of years healthcare systems have utilized various “-omics” approaches to
prognose, diagnose, and evaluate the treatment efficacy of cancer diseases. Metabolomics …

Pharmacometabolomics-Based Translational Biomarkers: How to Navigate the Data Ocean

V Bafiti, T Katsila - OMICS: A Journal of Integrative Biology, 2022 - liebertpub.com
Metabolome is the end point of the genome-environment interplay, and enables an
important holistic overview of individual adaptability and host responses to environmental …

Pharmacometabolomics: General Applications of Metabolomics in Drug Development and Personalized Medicine

DT Tran, A Dahlin - Metabolomics: Recent Advances and Future …, 2023 - Springer
Metabolomics is the study of small molecules (metabolites) present in cells, organs, and
body fluids. In contrast to genomic, proteomic, transcriptomic, and other “omics” data types …

Application of NMR-based metabolomics on biomedical research

F DI CESARE - 2022 - flore.unifi.it
Nuclear magnetic resonance (NMR)-based metabolomics is an emerging and robust-omic
science that deals with the systematic identification, characterization, and quantification of …